Clinical Trial Update: A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating whether applying tazarotene foam to the skin and exposing it to light causes a reaction in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• tazarotene foam (tazarotene)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED